Junling Zhuang

13PUBLICATIONS
29CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Medical virologyMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 19, 2026
Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.

|Jun 19, 2025
Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study.

Xijuan Lin, Chen Yang, Ziwei Liu

|Nov 23, 2024
Lenalidomide-induced pure red cell aplasia is associated with elevated expression of MHC-I molecules on erythrocytes.

Qi Hu, Yang Liu, Qiuyu Yue

|Aug 27, 2024
MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma.

Yuhang Song, Jianhua Du, Xianghong Jin

|Jun 07, 2024
Myc rearrangement redefines the stratification of high-risk multiple myeloma.

Xianghong Jin, Hui Li, Dingding Zhang

|Feb 12, 2024
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.

Yi Zhang, Hu Zhou, Zhongxing Jiang

Pageof 3

Frequent Collaborators

2 joint publications

Miao Chen

2 joint publications

Xijuan Lin

2 joint publications

Yuhang Song

2 joint publications

Xianghong Jin